Nan Fung Group Holdings’s Pacific Biosciences PACB Stock Holding History

Nan Fung Group Holdings’s Portfolio PACB Stock Details PACB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-274,488	Closed	-$376K	–	47
2024 Q2	$376K	Hold	274,488	–	–	0.4%	27
2024 Q1	$1.03M	Hold	274,488	–	–	0.95%	24
2023 Q4	$2.69M	Buy	274,488 +137,833	+101%	+$1.13M	1.68%	12
2023 Q3	$1.14M	Hold	136,655	–	–	0.92%	18
2023 Q2	$1.82M	Hold	136,655	–	–	1.16%	18
2023 Q1	$1.58M	Hold	136,655	–	–	1.08%	18
2022 Q4	$1.12M	Sell	136,655 -8,185	-6%	-$70.5K	0.77%	18
2022 Q3	$841K	Hold	144,840	–	–	0.54%	22
2022 Q2	$640K	Hold	144,840	–	–	0.44%	23
2022 Q1	$1.32M	Sell	144,840 -26,920	-16%	-$310K	0.63%	20
2021 Q4	$3.51M	Buy	+171,760	New	+$4.15M	1.04%	15

Other funds holding PACB

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Madrone Advisors Menlo Park, California $1.03B AUM 20.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

EDRH

Edmond de Rothschild Holding Chambesy, Switzerland $6.91B AUM 19.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Nan Fung Group Holdings's PACB Position: Q3 2024 in Review

Nan Fung Group Holdings sold out of Pacific Biosciences (PACB) in Q3 2024, closing a stake of 274,488 shares — an estimated $376K sold.

Nan Fung Group Holdings first reported a position in PACB in Q4 2021 and held it in 11 quarters. The position peaked at $3.51M in Q4 2021. 226 funds tracked by Wall St. Rank hold PACB as of Q3 2024.

Nan Fung Group Holdings reported no remaining Pacific Biosciences position as of Q3 2024 after selling out during the quarter.
Nan Fung Group Holdings sold 274,488 Pacific Biosciences shares in Q3 2024, an estimated $376K.
Nan Fung Group Holdings first reported a position in Pacific Biosciences in Q4 2021 and held it in 11 quarters.
Nan Fung Group Holdings's Pacific Biosciences position peaked at $3.51M in Q4 2021.
226 funds tracked by Wall St. Rank held Pacific Biosciences as of Q3 2024.

Based on Nan Fung Group Holdings's 13F filing for Q3 2024, filed 13 Nov 2024.